Mark Iwicki
2017
In 2017, Mark Iwicki earned a total compensation of $1.9M as Chief Executive Officer at Kala Pharmaceuticals.
Compensation breakdown
| Bonus | $387,450 |
|---|---|
| Option Awards | $967,676 |
| Salary | $500,588 |
| Other | $1,863 |
| Total | $1,857,577 |
Iwicki received $967.7K in option awards, accounting for 52% of the total pay in 2017.
Iwicki also received $387.5K in bonus, $500.6K in salary and $1.9K in other compensation.
Rankings
In 2017, Mark Iwicki's compensation ranked 5,864th out of 14,666 executives tracked by ExecPay. In other words, Iwicki earned more than 60.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,864 out of 14,666 | 60th |
Division Manufacturing | 2,135 out of 5,768 | 63rd |
Major group Chemicals And Allied Products | 667 out of 2,074 | 68th |
Industry group Drugs | 516 out of 1,730 | 70th |
Industry Pharmaceutical Preparations | 409 out of 1,329 | 69th |
Source: SEC filing on April 12, 2019.
Iwicki's colleagues
We found one more compensation record of an executive who worked with Mark Iwicki at Kala Pharmaceuticals in 2017.
2017
Kim Brazzell
Kala Pharmaceuticals